| Page 39 | Kisaco Research

A well-timed bridge investment can mean the difference between stalling and scaling. Dr. Asel Sartbaeva, CEO and co-founder of EnsiliTech, reflects on how family office support provided crucial bridge, enabled better deal terms, and positioned the company to close an oversubscribed £4.5 million round.

2024 Showcase Finalist
Milestone - Bridge Funding
Funding
Family Office
Companion and Livestock
Biopharma
Seed
Prevention
Treatment

Author:

Asel Sartbaeva

CEO
EnsiliTech

Asel Sartbaeva

CEO
EnsiliTech
 

Tom Weaver

Co-Founder & Chairman
PetMedix & ArkVax

Tom Weaver

Co-Founder & Chairman
PetMedix & ArkVax

Tom Weaver

Co-Founder & Chairman
PetMedix & ArkVax
 

Robert Hyde

Co-Founder and CTO
Vet Vision AI

Robert Hyde

Co-Founder and CTO
Vet Vision AI

Robert Hyde

Co-Founder and CTO
Vet Vision AI